An exploratory research investigating the appropriate usage and clinical evaluation of compound Monoammonium glycyrrhizinate Glycine DL-Methionine tablet on mild alopecia areata

Not Applicable

• Conditions: Mild alopecia areata

• Registration Number: JPRN-UMIN000009621
• Lead Sponsor: Institute of Health Biosciences ,The University of Tokushima Graduate School

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-12-28
• Study Completion: 2013-06-27
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who have advanced eczema and/or dermatitis of the scalp 2)Patients in whom three or more hairs are lost in hair pull test 3)Patients who have received oral steroid treatment, inhalation treatment, local steroid injection, or external steroid treatment for scalp within one month before the date of informed consent 4)Patients who have used medical products that claim promotion of hair growth, prevention of hair loss, or hair restoration action within one month before the date of informed consent 5)Patients with a history of allergic reaction to carpronium or glycyrrhizin 6)Patients diagnosed with malignant tumor 7)Patients with serious liver, renal, or cardiac disease 8)Patients who are breast-feeding, pregnant, possibly pregnant, or plan to become pregnant during the study period 9)In addition, patients who are determined as ineligible by the study doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified